NCM · Chemicals - Specialty
SenesTech, Inc. (SNES) Stock
$0.67
-7.36%
NCM: SNES
Basic Materials
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
SenesTech's Evolve® Delivers Significant Reduction in Rodent Damage at Texas Agricultural Operation
PR Newswire · Jul 9, 2026
SenesTech Appoints Jack Karabees as Executive Vice President of Sales
PR Newswire · Jun 29, 2026
SNES: Hantavirus Quarantine Ends, as Outbreak Underscores Need to Control Rodent Populations
Zacks Small Cap Research · Jun 23, 2026
SenesTech Expands Distribution of Evolve® Rodent Birth Control™ into Bermuda
PR Newswire · Jun 4, 2026
SenesTech Announces Amendment to Equity Incentive Plan Proposal
PR Newswire · Jun 3, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held4.21%
Institutions Held29.40%
Institutions Float Held30.69%
Peer Comparison
About SenesTech, Inc.
SenesTech, Inc. is led by CEO Joel L. Fruendt, employs 23 people, headquartered in US, publicly traded since 2016.
SenesTech, Inc. (SNES) stock trades at $0.67 with a market capitalization of $3.55M. The stock is valued at a price-to-earnings (P/E) ratio of -0.57, price-to-book of 0.68, price-to-sales of 1.74. Over the past 52 weeks the stock has ranged between $0.63 and $4.45, and currently trades 84.9% below its 52-week high.
On profitability, SenesTech, Inc. generates a return on equity (ROE) of -80.73%, return on capital employed of -85.63%, an operating margin of -350.00%, a net profit margin of -294.73%.